Durham-based Atsena Therapeutics has raised $150 million to advance gene therapies for preventing or reversing types of ...

As part of the Distinguished Speaker Series, Charlotte Biology and Biotechnology (CBB) Exchange Group presents "Succinate Signaling Mediated Host-Microbial Interactions in Inflammatory Diseases," ...

VQ Biomedical, spun out of Duke University, has developed a novel, minimally invasive catheter designed to deliver oxygen directly to the bloodstream. The catheter bypasses the lungs, giving ARDS ...

Greater Charlotte is home to a robust, expanding life sciences cluster with a plethora of international firms. Assets in the region span medtech/medical device development and manufacturing, ...

Networking. Training events. Employment opportunities. NCBiotech can connect you with the next job or company you need to advance your career in life sciences. North Carolina is home to 840 life ...

In his talk, Dr. Perou will share his journey from research to entrepreneurship, highlighting the challenges and lessons learned in transforming his cancer genomics research into a successful startup ...

Hear from dynamic founders who are building successful businesses in innovative industries. As part of UNC's Insight and Action Series, this event will showcase the journeys and lessons learned by ...

Durham-based Precision BioSciences Inc. has received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for PBGENE-HBV, an in vivo gene editing program designed ...

Atsena Therapeutics raises $150M for ocular gene therapy programs Durham-based Atsena Therapeutics has raised $150 million to advance gene therapies for preventing or reversing types of inherited ...

Gov. Roy Cooper announced today that Believer Meats, an Israeli company that is commercializing cultivated meat made from animal cells, plans to build a $123 million, 200,000-square-foot manufacturing ...